Royalty Pharma - 2 Year Dividend History | RPRX
Historical dividend payout and yield for Royalty Pharma (RPRX) since 2022. The current TTM dividend payout for Royalty Pharma (RPRX) as of December 20, 2024 is $0.84. The current dividend yield for Royalty Pharma as of December 20, 2024 is 3.46%.
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Finance - Miscellaneous Services |
$14.305B |
$2.355B |
|
Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
